Genetic Dilated Cardiomyopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-27
Clinical Trial Update: A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy [Phase 2, Phase 3]
Clinical trial update indicates a phase 2/3 study of danicamtiv for symptomatic genetic dilated cardiomyopathy is actively recruiting.